Related references
Note: Only part of the references are listed.Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells
Colleen M. Britain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
The sialyltransferase ST6GAL1 protects against radiation-induced gastrointestinal damage
Patrick R. Punch et al.
GLYCOBIOLOGY (2020)
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Stefan Mereiter et al.
CANCER CELL (2019)
Drug resistance related to aberrant glycosylation in colorectal cancer
Ninon Very et al.
ONCOTARGET (2018)
Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis
Joana G. Rodrigues et al.
CELLULAR IMMUNOLOGY (2018)
The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1 alpha signaling
Robert B. Jones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
Haiying Zhang et al.
NATURE CELL BIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome
Yoshiki Narimatsu et al.
GLYCOBIOLOGY (2018)
The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential
Colleen M. Britain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Differential expression of ST6GAL1 in the tumor progression of colorectal cancer
Sen Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression
Stephanie Holst et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
Matthew J. Schultz et al.
CANCER RESEARCH (2016)
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells
Mohit P. Mathew et al.
ONCOTARGET (2016)
Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
Jishun Lu et al.
MOLECULES (2015)
N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes
Karol Kaszuba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Glycosylation Characteristics of Colorectal Cancer
Stephanie Holst et al.
GLYCOSYLATION AND CANCER (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression
Fabio Dall'Olio et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
Diego O. Croci et al.
CELL (2014)
β-Galactoside α2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-β-mediated Epithelial-Mesenchymal Transition
Jishun Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
ST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines
Amanda F. Swindall et al.
CANCER RESEARCH (2013)
Increasing the α 2, 6 Sialylation of Glycoproteins May Contribute to Metastatic Spread and Therapeutic Resistance in Colorectal Cancer
Jung-Jin Park et al.
GUT AND LIVER (2013)
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
Matthew J. Schultz et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells
Jung-Jin Park et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Emerging Role of α2,6-Sialic Acid as a Negative Regulator of Galectin Binding and Function
Ya Zhuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells
Amanda F. Swindall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lipid Raft Localization of EGFR Alters the Response of Cancer Cells to the EGFR Tyrosine Kinase Inhibitor Gefitinib
Mary E. Irwin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells
Ying-Chih Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells
A. S. Carvalho et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Alberto Bardelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Synthesis and expression of CDw75 antigen in human colorectal cancer
Clotilde Costa-Nogueira et al.
BMC CANCER (2009)
Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis
Hua-Bei Guo et al.
GLYCOBIOLOGY (2009)
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells
Joseph N. Contessa et al.
CANCER RESEARCH (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cetuximab for the treatment of colorectal cancer
Derek J. Jonker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hypersialylation of β1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility
EC Seales et al.
CANCER RESEARCH (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Characterization of glycosylation sites of the epidermal growth factor receptor
YJ Zhen et al.
BIOCHEMISTRY (2003)
Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors
Y Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor
C Sato et al.
JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
